ADIPOQ and systemic sclerosis: Decreased levels of adiponectin were associated with more advanced skin sclerosis and a higher incidence of pulmonary fibrosis, suggesting that adiponectin concentration may be a useful marker for assessing fibrosis in the course of SSc [48].